| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1249 | 911 | 140 |
| Full Text Views | 24 | 3 | 0 |
| PDF Downloads | 28 | 4 | 0 |
In Vitro Effects of Primaquine and Primaquine Metabolites on Exoerythrocytic Stages of Plasmodium berghei
Michelle D. Bates
Michelle D. Bates
Biomedical Research Institute, City University of New York Medical School, City College, Rockville, Maryland
Search for other papers by Michelle D. Bates in
Current site
Google Scholar
PubMed
Search for other papers by Michelle D. Bates in
Current site
Google Scholar
PubMed
Steven R. Meshnick
Steven R. Meshnick
Biomedical Research Institute, City University of New York Medical School, City College, Rockville, Maryland
Search for other papers by Steven R. Meshnick in
Current site
Google Scholar
PubMed
Search for other papers by Steven R. Meshnick in
Current site
Google Scholar
PubMed
Cynthia I. Sigler
Cynthia I. Sigler
Biomedical Research Institute, City University of New York Medical School, City College, Rockville, Maryland
Search for other papers by Cynthia I. Sigler in
Current site
Google Scholar
PubMed
Search for other papers by Cynthia I. Sigler in
Current site
Google Scholar
PubMed
Pamela Leland
Pamela Leland
Biomedical Research Institute, City University of New York Medical School, City College, Rockville, Maryland
Search for other papers by Pamela Leland in
Current site
Google Scholar
PubMed
Search for other papers by Pamela Leland in
Current site
Google Scholar
PubMed
Michael R. Hollingdale
Michael R. Hollingdale
Biomedical Research Institute, City University of New York Medical School, City College, Rockville, Maryland
Search for other papers by Michael R. Hollingdale in
Current site
Google Scholar
PubMed
Search for other papers by Michael R. Hollingdale in
Current site
Google Scholar
PubMed
The antimalarial activities of primaquine and its metabolites against exoerythrocytic (EE) stages of Plasmodium berghei in vitro were compared with their abilities to spontaneously generate activated oxygen. A quantitative relationship between the number of sporozoites and the number of EE merozoites produced was established. The reduction in the number of merozoites was used as an assay of drug activity. The ED50 of primaquine, 3.7–3.9 × 10-6 M, was the concentration of drug that reduced the number of merozoites to 50% of controls. Several of the primaquine metabolites were much more potent than primaquine, with ED50s as low as 2 × 10-7 M. Metabolites containing the 4-amino-1-methylbutyl side chain were most effective in vitro. Superoxide generation was measured for the various metabolites. In general, superoxide generation did not correlate with antimalarial activity. However, for the 3 metabolites with 4-amino-1-methylbutyl side chains, there was a correlation between superoxide generation and antimalarial activity.
Author Notes
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1249 | 911 | 140 |
| Full Text Views | 24 | 3 | 0 |
| PDF Downloads | 28 | 4 | 0 |